Modulation by nitric oxide of prostaglandin biosynthesis in the rat
Open Access
- 1 January 1995
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 114 (2) , 323-328
- https://doi.org/10.1111/j.1476-5381.1995.tb13230.x
Abstract
Modulation of prostaglandin biosynthesis in vivo by either exogenous or endogenous nitric oxide (NO) has been studied in the rat using arachidonic acid (AA)‐induced paw oedema and measuring both the foot volume and the amount of 6‐keto‐prostaglandin F1α (6‐keto‐PGF1α), the stable metabolite of prostacyclin (PGI2), in the oedematous fluid recovered from inflamed paws. Paw injections of 150 or 300 nmol of AA were virtually inactive whereas 600 nmol produced a moderate oedema which was greatly reduced by the NO synthase inhibitor l‐NG‐nitro arginine methyl ester (l‐NAME, 100 nmol/paw) and the NO scavenger haemoglobin (Hb, 30 μmol/paw), but unaffected by the inhibitor of the soluble guanylate cyclase, methylene blue (Mb, 3 μmol/paw) and L‐arginine (15 μmol/paw). The NO‐donors (10 μmol/paw) 3‐morpholino‐sydnonimine‐hydrochloride (SIN‐1), S‐nitroso‐N‐acetyl‐d, l‐penicillamine (SNAP) and sodium nitroprusside (SNP) significantly potentiated the paw oedema induced by AA (300 nmol/paw). SIN‐1 (2.5, 5 and 10 μmol/paw) produced a significant dose‐dependent increase of the oedema induced by AA which was correlated with increased amounts of 6‐keto‐PGF1α in the fluid recovered from inflamed paws. Both oedema and prostaglandin biosynthesis induced by the combination AA + SIN‐1 were greatly suppressed by either Hb (30 μmol/paw) or indomethacin (3 μmol/paw or 5 mg kg−1 s.c.) but unaffected by Mb (3 μmol/paw). In LPS‐treated rats (6 mg kg−1, i.p.) doses of AA inactive in normal animals produced a remarkable oedema which was reduced by l‐NAME or Hb, unaffected by Mb and increased by l‐arginine. These results demonstrate that NO increases prostaglandin biosynthesis in vivo through a guanosine 3′:5′‐cyclic monophosphate (cyclic GMP)‐independent mechanism and suggest that the interaction between NO synthase and cyclo‐oxygenase (COX) pathways may represent an important mechanism for the modulation of the inflammatory response.Keywords
This publication has 28 references indexed in Scilit:
- Suppression of low dose streptozotocin induced diabetes in mice by administration of a nitric oxide synthase inhibitorLife Sciences, 1991
- Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthasesFEBS Letters, 1991
- In vitro cytokine release by activated murine peritoneal macrophages: Role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6Cytokine, 1991
- Glucocorticoids inhibit the induction of nitric oxide synthase in macrophagesBiochemical and Biophysical Research Communications, 1990
- Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice.Journal of Clinical Investigation, 1990
- Molecular Aspects Underlying the Vasodilator Action of MolsidomineJournal of Cardiovascular Pharmacology, 1989
- Nitric oxide: A cytotoxic activated macrophage effector moleculeBiochemical and Biophysical Research Communications, 1988
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Screens for anti-inflammatory drugsJournal of Pharmacy and Pharmacology, 1971